10-K: eHealth Reports Strong Profit Growth Amidst Membership Declines
Annual Report
eHealth, Inc. posted a significant increase in net income and operating income for 2025, driven by higher commission revenue and improved Medicare product lifetime values, despite a decrease in total approved members and overall estimated membership.
Summary
- Total revenue increased by 4% to $554.0 million in 2025, up from $532.4 million in 2024.
- Commission revenue grew by 8% to $498.0 million in 2025, compared to $461.6 million in 2024, primarily from the Medicare segment.
- Net income surged by 298% to $40.0 million in 2025, from $10.1 million in 2024.
- Income from operations increased by 182% to $66.5 million in 2025, up from $23.6 million in 2024.
- Net loss attributable to common stockholders improved to $(10.4) million in 2025, from $(35.0) million in 2024.
- Total approved members declined by 3% to 471,457 in 2025, down from 485,456 in 2024.
- Medicare approved members decreased by 7%, while ancillary approved members increased by 40%.
- Estimated constrained Lifetime Value (LTV) of commissions per approved member increased for Medicare Advantage (+6% to $1,154), Medicare Supplement (+31% to $1,430), and Medicare Part D (+27% to $219).
- Total estimated membership decreased by 3% to 1,250,753 as of December 31, 2025, from 1,293,796 as of December 31, 2024.
- Operating cash outflow increased to $25.3 million in 2025, from $18.4 million in 2024.
- A new $125.0 million asset-based revolving credit facility was secured on December 31, 2025, with proceeds used to repay a previous term loan.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing with a moderately positive sentiment. While significant improvements in net income and operating income, coupled with enhanced Medicare LTVs and strategic AI adoption, are strong positives, the declines in overall membership and increased operating cash outflow present ongoing challenges. The workforce reduction and legal proceedings also temper the overall outlook.
Positives
- Net income saw a substantial increase of 298% to $40.0 million in 2025.
- Income from operations grew by 182% to $66.5 million, indicating improved operational efficiency.
- Commission revenue increased by 8%, primarily driven by the Medicare segment.
- Estimated constrained Lifetime Value (LTV) of commissions per approved member improved across all Medicare products, with Medicare Supplement LTV up 31% and Medicare Part D LTV up 27%.
- Ancillary approved members increased significantly by 40%, largely due to targeted growth in hospital indemnity plans.
- Total acquisition cost per MA-equivalent approved member decreased by 1%, reflecting marketing efficiencies and improved lead quality.
- Successfully scaled Artificial Intelligence (AI) screener, leading to increased efficiencies and reduced call wait times.
- Strengthened capital structure with a new $125.0 million asset-based revolving credit facility, offering favorable terms and extended maturity.
- Maintained HITRUST i1 certification for the carrier integration platform since 2024, demonstrating strong information security practices.
- Earned 'Great Place to Work Certified' recognition for the second consecutive year in 2025, indicating high employee satisfaction.
Negatives
- Total approved members declined by 3% in 2025 compared to 2024.
- Medicare approved members decreased by 7%, including a 3% drop in Medicare Advantage and a 63% decrease in Medicare Part D approved members.
- Individual and family plan and small business health insurance plan approved members declined by 25% and 6% respectively.
- Other revenue decreased by 21%, primarily due to a reduction in sponsorship and advertising revenue.
- Operating cash outflow increased to $25.3 million in 2025 from $18.4 million in 2024.
- Total acquisition cost per IFP-equivalent approved member increased by 14%.
- Regulatory changes in 2025 removed special enrollment periods for dual-eligible and LIS beneficiaries, leading to a decline in Medicare plan submissions during the second and third quarters.
- The company has not met the Minimum Asset Coverage Ratio since September 30, 2023, and was not in compliance with the Minimum Liquidity Amount as of November 30, 2024, under the H.I.G. Investment Agreement.
- Interest income decreased by $3.3 million due to less favorable short-term investment rates and fewer short-term marketable securities.
- A reduction in force was implemented in January 2026, eliminating approximately 14% of the workforce.
Risks
- Intense competition in the health insurance market, including from government-run exchanges and direct-to-consumer channels, could harm business and increase customer acquisition costs.
- Changes in healthcare laws and regulations, including the Affordable Care Act and CMS rules for Medicare plans, could adversely impact business operations, demand for services, and commission rates.
- Loss or modification of relationships with health insurance carriers, or impairment of their businesses, could reduce product offerings, lower commissions, and harm profitability.
- Inability to successfully attract and convert qualified prospects into members, or to retain existing members, would adversely impact business, operating results, and financial condition.
- Marketing and brand promotion efforts may be unsuccessful, increasingly costly, or limited by evolving technology (e.g., AI-driven search), regulatory requirements, or partner practices.
- Dependence on the ability to timely recruit, train, and retain qualified licensed insurance agents (benefit advisors) and other personnel, especially during seasonal enrollment periods, while managing labor costs.
- Business seasonality, particularly the concentration of enrollments and expenses in the fourth quarter, poses operational challenges and risks if not managed effectively.
- Factors impacting the constrained estimated lifetime value (LTV) of commissions per approved member, such as reduced conversion rates, declining plan duration, or lower commission amounts, could harm financial performance.
- Concentration of a significant portion of revenue from a small number of health insurance carriers makes the business vulnerable to changes in these relationships.
- Unsuccessful carrier advertising and sponsorship programs could harm revenue generation.
- Inefficiency in enrolling subsidy-eligible individuals through government-run health insurance exchanges could lead to loss of members or increased expenses.
- Failure to successfully execute operational and strategic plans, including diversification efforts and cost savings initiatives, could harm business and financial condition.
- Changes in senior management or other key employees, or difficulty in attracting and retaining qualified personnel, could affect business operations and financial results.
- Operations in China involve risks related to evolving laws, data transfer restrictions, geopolitical tensions, and potential relocation costs.
- Self-insurance programs for employee health benefits may expose the company to significant and unexpected costs and losses.
- Exposure to various legal proceedings, including litigation, government enforcement actions (e.g., False Claims Act lawsuit), or regulatory inquiries, could result in significant liability, fines, and reputational harm.
- Failure to maintain health insurance licenses and comply with numerous, complex, and frequently changing laws and regulations applicable to the sale of health insurance could prevent business operations.
- Dependence on maintaining and improving functioning information technology systems, especially during key enrollment periods, makes the business vulnerable to system failures, disruptions, and increased volume.
- Security risks, including cyberattacks or data breaches, or inability to safeguard confidential data, could harm business, reputation, and expose the company to liability.
- Increasing regulatory focus on privacy and data security issues and expanding laws could impact business and expose the company to increased liability.
- Issues relating to the use of new and evolving technologies, such as artificial intelligence, in business operations could result in liability, reputational harm, and adverse financial impact.
- Inaccurate or untimely commission or member data reports from carriers could harm business, operating results, and the ability to accurately estimate membership and recognize revenue.
- Agreements with lenders and convertible preferred stock investors contain restrictions and covenants that could materially adversely affect liquidity and financial condition.
- Future operating results are likely to fluctuate and could fall short of guidance and expectations, negatively affecting common stock value.
- The price of common stock has been and may continue to be volatile, leading to potential investment decline.
- Adverse macroeconomic conditions, including slow growth, recession, high unemployment, inflation, and financial market disruptions, could materially adversely affect business.
Future Outlook
The company plans to focus on a lifetime advisory model to enhance member lifetime value, improve retention, and build brand loyalty within its Medicare segment, while also broadening ancillary product offerings. It intends to drive employer plan growth in the under 65 market through ICHRA diversification and alliance-based investments. Management aims for meaningful improvement in operating cash flows, a focus on direct branded marketing channels for higher-margin enrollments, and continued cost savings efforts. The company will also advance its digital technology leadership, leveraging its AI Center of Excellence, and fortify carrier partnerships, anticipating a fluid Medicare market.
Management Comments
- "We were well positioned to execute successfully during this past AEP with our more tenured benefit advisors, stronger branded marketing channels, and our expanded member retention program."
- "We continued to elevate the consumer experience, focus on enrollment quality, build our distinctive brand that resonates with our consumers and accelerate technological innovation."
- "We scaled our Artificial Intelligence (AI) screener during this past AEP, which resulted in increased efficiencies to our model while reducing call wait times."
- "We also invested in expanding growth in hospital indemnity plans and Medicare Supplement plans, both of which contributed favorably to our business throughout the year."
- "Our direct branded marketing channels performed well during AEP and as a result, we strategically reduced marketing spend on partner marketing channels."
- "We also observed improved Medicare Advantage unit margins driven by improved LTVs for all Medicare products, reflecting favorable commission dynamics and stable retention trends, disciplined fixed-cost management and continued strength in our commissions receivable."
- "We believe this trend will continue into 2026, but that the longer-term growth potential of the Medicare Advantage market remains strong."
- "Ultimately, when the Medicare Advantage market resumes growth, we believe we will be in a strong position to accelerate and scale as needed."
Industry Context
StockSavvy.ai notes that the health insurance industry, particularly the Medicare Advantage market, experienced significant disruptions in 2025 due to higher medical costs and regulatory pressures, leading carriers to adjust offerings and focus on profitability over volume. This environment spurred elevated consumer activity during the Annual Enrollment Period. The broader market is seeing a growing consumer propensity for comparison shopping and an increasing shift towards digital and mobile-first engagement, which eHealth aims to capitalize on with its omnichannel platform and AI integration. The employer market is also evolving with increased adoption of alternative products like ICHRAs, presenting diversification opportunities. Competition remains intense from government exchanges, direct carrier sales, and other brokers, necessitating continuous innovation and cost management.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Fran Soistman | Derrick A. Duke | July 28, 2025 | CEO transition, with Fran Soistman's letter agreement dated June 18, 2025. |
| Chief Financial Officer | NA | John J. Dolan | August 31, 2024 | Appointment as Chief Financial Officer, with a severance agreement dated August 31, 2024. |
| Chief Revenue Officer | NA | NA | 2024 or 2025 | Appointment of a new Chief Revenue Officer mentioned as part of senior leadership changes. |
| Workforce | NA | NA | January 2026 | Reduction in force, eliminating approximately 14% of the workforce, as part of cost savings initiatives. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Nomination Rights | H.I.G., the convertible preferred stock investor, has the right to nominate one additional board member if the company fails to maintain the Minimum Asset Coverage Ratio or Minimum Liquidity Amount. H.I.G. designated a board observer on March 13, 2024. | March 13, 2024 (board observer designation) | Increases H.I.G.'s influence over the company's governance and strategic decisions, potentially aligning or diverging from common stockholders' interests. |
| Strategy Committee | A new strategy committee of the Board of Directors was established, with H.I.G. having the right to designate one member and an observer to the committee. | December 31, 2025 (via H.I.G. Investment Agreement Amendment) | Provides H.I.G. with direct involvement in strategic oversight, potentially influencing the company's long-term direction. |
| Covenant Protections | The H.I.G. Investment Agreement Amendment provides additional governance and covenant protections to H.I.G., including with respect to additional debt incurrence and information rights related to the company's annual budget. | December 31, 2025 | Further restricts the company's financial and operational flexibility, requiring H.I.G.'s consent for certain actions and increasing reporting obligations. |
| Insider Trading Policy | The Insider Trading Policy was amended. | December 16, 2025 | Enhances compliance with federal and state securities laws and regulations, aiming to minimize legal and reputational risk related to insider trading. |
Legal Proceedings
- A qui tam action, United States ex rel. Andrew Shea v. eHealth, Inc. et al, was unsealed on May 1, 2025, alleging violations of the Federal False Claims Act related to Medicare Advantage enrollment and marketing activities.
- The U.S. Attorney's Office for the District of Massachusetts filed a complaint intervening in part in the qui tam action.
- The court granted a motion to stay the Relator's claims until January 21, 2026, later extended to May 13, 2026.
- eHealth filed two motions to dismiss all claims on August 19, 2025, with oral arguments held on January 21, 2026.
- eHealth filed a motion for leave to depose the Relator regarding privileged documents on December 9, 2025.
Related Party Transactions
- The investment agreement with Echelon Health SPV, LP (H.I.G.) for Series A convertible preferred stock grants H.I.G. significant rights, including board nomination rights, dividend preferences, redemption rights, and approval rights over certain corporate actions and the annual budget if specific covenants are breached. This relationship was further amended on December 31, 2025, in connection with the new revolving credit facility.
Stakeholder Impact
- Shareholders: Potential for increased value due to improved profitability and strategic initiatives, but diluted voting power and preferential rights of preferred stockholders (H.I.G.) could be a concern. Stock price volatility remains a risk.
- Employees: A reduction in force in January 2026 (14% of workforce) indicates job insecurity for some, but efforts to improve employee experience (Great Place to Work certification) and development programs aim to retain talent.
- Customers (Beneficiaries): Continued focus on consumer-centricity, omnichannel engagement, AI-driven efficiencies, and expanded product offerings aim to improve customer experience and choice, despite regulatory changes impacting enrollment periods for some.
- Health Insurance Carriers: Strengthened carrier relationships and improved enrollment quality are positive, but regulatory pressures and shifts in carrier strategies (e.g., focus on profitability over volume) continue to influence partnerships.
- Creditors: The new $125.0 million revolving credit facility provides enhanced liquidity and an extended maturity, improving the company's debt profile, but covenants impose restrictions.
Next Steps
- Focus on utilizing the lifetime advisory model to drive increased member lifetime value, improved retention, and build brand recognition and loyalty for the Medicare segment.
- Broaden ancillary product selection, building on the growth achieved with Hospital Indemnity Plans in 2025.
- Leverage the lifetime advisory model to drive measured employer plan growth in the under 65 market by accelerating diversification through ICHRA.
- Provide meaningful improvement in operating cash flows.
- Focus on direct branded marketing channels to attract higher-margin enrollments.
- Continue cost savings efforts to preserve profitability.
- Continue advancing digital technology leadership and utilizing the AI Center of Excellence.
- Fortify the organizational foundation that supports health insurance carrier relationships through a strategic approach to carrier portfolio management.
- Address the qui tam action and motions to dismiss in the legal proceedings, with a court hearing held on January 21, 2026, and a stay extended until May 13, 2026.
Key Dates
| Date | Description |
|---|---|
| February 17, 2021 | eHealth entered into an investment agreement with Echelon Health SPV, LP (H.I.G.) for the sale of Series A convertible preferred stock. |
| April 30, 2021 | Closing date of the private placement with H.I.G., where eHealth received $214.0 million in net proceeds from the sale of Series A Preferred Stock. |
| February 28, 2022 | eHealth entered into a $70.0 million secured term loan credit facility with Blue Torch Finance LLC. |
| August 16, 2022 | First amendment to the Original Credit Agreement with Blue Torch Finance LLC, replacing LIBOR with Adjusted Term SOFR as a reference rate. |
| September 30, 2023 | eHealth failed to maintain the Minimum Asset Coverage Ratio as required by the H.I.G. Investment Agreement. |
| January 1, 2024 | Effective date of a severance agreement between Michelle Barbeau and eHealth, Inc. |
| March 13, 2024 | Nominating and Corporate Governance Committee approved the appointment of a board observer designated by H.I.G. |
| June 12, 2024 | Amended and Restated 2024 Equity Incentive Plan adopted upon stockholder approval, replacing the 2014 Equity Plan. |
| August 31, 2024 | Effective date of a severance agreement between John Dolan and eHealth, Inc. |
| November 1, 2024 | Second amendment to the First Amended Credit Agreement with Blue Torch Finance LLC, extending maturity to February 2026 and adjusting margins. |
| November 30, 2024 | eHealth was no longer in compliance with the Minimum Liquidity Amount under the H.I.G. Investment Agreement. |
| December 31, 2024 | End of fiscal year 2024. |
| May 1, 2025 | Qui tam action (United States ex rel. Andrew Shea v. eHealth, Inc. et al) unsealed, and the U.S. Attorney's Office filed a complaint intervening in part. |
| June 18, 2025 | Amended and Restated 2024 Equity Plan amended to reserve an additional 1,500,000 shares of common stock. |
| June 18, 2025 | CEO Transition Letter Agreement dated between Fran Soistman and eHealth, Inc. |
| July 28, 2025 | CEO Offer Letter dated between Derrick Duke and eHealthInsurance Services, Inc. |
| July 30, 2025 | eHealth jointly filed an unopposed motion to stay the Relator's claims in the legal proceeding. |
| August 4, 2025 | Severance Agreement dated between Derrick Duke and eHealth, Inc. |
| August 15, 2025 | Court granted the motion to stay Relator's claims until January 21, 2026. |
| August 19, 2025 | eHealth jointly filed two motions to dismiss all claims against eHealth in the legal proceeding. |
| October 6, 2025 | Third amendment to the Second Amended Credit Agreement, extending maturity to January 2027. |
| October 15 December 7 (annually) | Medicare Annual Enrollment Period (AEP). |
| November 1 December/January 15 (annually) | Individual and Family Health Insurance Open Enrollment Period (OEP) for most states. |
| December 9, 2025 | eHealth filed a motion for leave to depose the Relator regarding privileged documents. |
| December 16, 2025 | Insider Trading Policy amended. |
| December 19, 2025 | eHealth filed joint replies to the government's oppositions to motions to dismiss. |
| December 23, 2025 | Government and Relator filed oppositions to eHealth's deposition motion. |
| December 30, 2025 | eHealth filed a reply brief to the oppositions to the deposition motion. |
| December 31, 2025 | End of fiscal year 2025. Entered into a new $125.0 million revolving credit facility and repaid the previous term loan. First amendment to the H.I.G. Investment Agreement also entered. |
| January 1 March 31 (annually) | Medicare Advantage Open Enrollment Period (OEP). |
| January 2026 | Implemented a reduction in force, eliminating approximately 14% of the workforce. |
| January 21, 2026 | Court heard oral argument on the deposition motion and motions to dismiss, taking both matters under submission. |
| February 20, 2026 | Number of shares of common stock outstanding was 31,073,002. |
| February 26, 2026 | Date of the Annual Report on Form 10-K filing. |
| May 13, 2026 | Extended stay in the Relator's case until the resolution of the pending motion to dismiss or this date, whichever occurs first. |
| April 30, 2027 | Earliest date for H.I.G.'s redemption rights for Series A Preferred Stock. |
| December 2028 | Maturity date of the new Revolving Credit Facility. |
Recommendation
holdeHealth, Inc. demonstrated strong improvements in profitability and operational efficiency in 2025, with net income and operating income surging. The company's strategic focus on its lifetime advisory model, AI integration, and enhanced Medicare LTVs are positive indicators for future performance. However, the decline in total approved members and overall estimated membership, coupled with increased operating cash outflow, suggests ongoing challenges in growth and cash generation. The existing non-compliance with certain covenants of the H.I.G. Investment Agreement and the ongoing legal proceedings introduce elements of uncertainty and risk. While the new credit facility strengthens the capital structure, the mixed operational results and external pressures warrant a 'hold' recommendation, advising investors to monitor the execution of strategic plans and resolution of legal matters before making further investment decisions.
Keywords
Health Insurance, Medicare Advantage, Medicare Supplement, Medicare Part D, Insurance Marketplace, SEC Filing, 10-K, Financial Results, Commission Revenue, Lifetime Value, Approved Members, Digital Health, AI, Regulatory Compliance, Capital Structure, EHTH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.